(387) Sensitivity analyses of the primary efficacy endpoint in a phase 2 randomized, placebo-controlled study of gabapentin enacarbil (GEn) in patients with neuropathic pain associated with postherpetic neuralgia (PHN)

✍ Scribed by Calkins, A.; Gudin, J.; Gidal, B.; Jaros, M.; Kim, R.; Shang, G.

• Book ID: 122258219
• Publisher: Elsevier Science
• Year: 2014
• Tongue: English
• Weight: 92 KB
• Volume: 15
• Category: Article
• ISSN: 1528-8447
• DOI: 10.1016/j.jpain.2014.01.298